Cargando...
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
There is growing interest in identifying predictive biomarkers for inhibitors of programmed cell death protein 1 receptor (PD-1), programmed death ligand 1 (PD-L1), and cytotoxic T-lymphocyte associated protein 4 (CTLA-4). Given the links between the stool microbiota, anticancer immunosurveillance,...
Guardado en:
| Publicado en: | Clin Transl Med |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6423251/ https://ncbi.nlm.nih.gov/pubmed/30887236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-019-0225-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|